BEST SCIENCE FOR THE MOST NEGLECTED
We develop life-saving medicines for people with neglected diseasesĀ around the world
BEST SCIENCE FOR THE MOST NEGLECTED
We develop lifesaving medicines for people with neglected diseases around the world
DNDi puts patients – not profits – at the heart of R&D
Millions of people around the world die every year from lack of treatment. Yet only a fraction of the worldā€™s pharmaceutical research and development focuses on diseases affecting poor and vulnerable communities.
The Drugs for Neglected Diseases initiative discovers, develops, and delivers treatments for neglected communities around the world suffering from diseases for which there are few ā€“ if any ā€“ effective treatments.
FEATURED
The Kissing Bug Doctors of Florida
Over 300,000 people live with Chagas disease in the US, but very few people have been tested and treated. In Gainesville, Florida, a group of scientists and doctors led by Dr Norm Beatty at the Emerging Pathogens Institute are trying to end the neglect of this parasitic killer.
Saving millions of lives since 2003
Among DNDiā€™s thirteen treatments delivered are fexinidazole (2018), the first-ever all-oral treatment for sleeping sickness; and a child-friendly, sweet-tasting treatment for children living with HIV (2022).
Our goal: 25 patient-friendly treatments by 2028
We work with more than 200 partners worldwide to deliver treatments that are affordable and specifically designed for the people and places in most need.
Be part of making medical history
Join a team of scientists and healthcare workers working to speed up research to deliver life-saving treatments for the most neglected
Born on the frontlines of medical action
When the medical humanitarian organization Doctors Without Borders / MĆ©decins Sans FrontiĆØres (MSF) received the Nobel Peace Prize in 1999, they dedicated a portion of the award to exploring a new, alternative, not-for-profit model for developing drugs for neglected patients.
In 2003, DNDi was founded by MSF, the World Health Organization, Institut Pasteur, the Indian Council of Medical Research, the Oswaldo Cruz Foundation in Brazil, the Kenya Medical Research Institute, and the Malaysian Ministry of Health.
Today, we collaborate with pharmaceutical companies, ministries of health, academia, civil society, and patient groups to innovate for neglected populations. Working at every stage of the drug development process, we pioneer open-source drug discovery to find new compounds for neglected diseases, conduct clinical trials in the worldā€™s most remote areas, and ensure equitable access to the treatments we develop.
Founded in 2003
Researching 10+ diseases affecting the most vulnerable
20+ clinical studies under way
At 50+ sites in 15+ countries
Help neglected patients
DNDiā€™s generous supporters make sure we can take on the devastating diseases affecting the people who need our help the most. Help us reach our goal of 25 new treatments by 2028!
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.Ā
